Call for Abstract
3rd Euro-Global Conference on Infectious Diseases, will be organized around the theme “Advances & Improving Treatment and Prevention of Infectious Diseases”
Euro Infectious Diseases 2016 is comprised of 16 tracks and 306 sessions designed to offer comprehensive sessions that address current issues in Euro Infectious Diseases 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Viral Infectious Disease occurs when an organism's body is invaded by pathogenic viruses, and infectious virus particles (virions) attach to and enter susceptible cells. There are many types of viruses that cause a wide variety of viral diseases. The most common type of viral disease is the common cold, which is caused by a viral infection of the upper respiratory tract (nose and throat). Viral diseases are contagious and spread from person to person when a virus enters the body and begins to multiply. Viral diseases result in a wide variety of symptoms that vary in character and severity depending on the type of viral infection and other factors, including the person’s age and overall health.
- Track 1-1Viral molecular epidemiology
- Track 1-2Measles, Mumps, and Rubella
- Track 1-3Polio
- Track 1-4Pox Disease
- Track 1-5Ecology and Others
- Track 1-6Virology
- Track 1-7Viral hepatitis
- Track 1-8Rotavirus
- Track 1-9Hantavirus
- Track 1-10Smallpox
- Track 1-11Rabies
- Track 1-12Marburg virus
- Track 1-13Human Immunodeficiency virus / Acquired Immunodeficiency Syndrome
- Track 1-14Respiratory viruses
- Track 1-15Influenza
- Track 1-16Zoonotic viral diseases
- Track 1-17Hemorrhagic Fevers and Acute Viral Infections
Bacteria are living things that have only one cell. Under a microscope, they look like balls, rods, or spirals. They are so small that a line of 1,000 could fit across a pencil eraser. Most bacteria won't hurt you - less than 1 percent of the different types make people sick. Many are helpful. Some bacteria help to digest food, destroy disease-causing cells, and give the body needed vitamins. Bacteria are also used in making healthy foods like yogurt and cheese. But infectious bacteria can make you ill. They reproduce quickly in your body. Many give off chemicals called toxins, which can damage tissue and make you sick. Examples of bacteria that cause infections include Streptococcus, Staphylococcus, and E. coli. Antibiotics are the usual treatment. When you take antibiotics, follow the directions carefully. Each time you take antibiotics, you increase the chances that bacteria in your body will learn to resist them causing antibiotic resistance. Later, you could get or spread an infection that those antibiotics cannot cure.
- Track 2-1Mycobacterial Infections
- Track 2-2Ecology and Others
- Track 2-3Central nervous system infections
- Track 2-4Bone & Joint Infections
- Track 2-5Urinary Tract Infections
- Track 2-6Genital infections
- Track 2-7Respiratory infections
- Track 2-8Bacteraemia & Endocarditis
- Track 2-9Anthrax
- Track 2-10Pneumonia
- Track 2-11Tuberculosis
- Track 2-12Gonorrhea
- Track 2-13Syphilis
- Track 2-14Plague
- Track 2-15Cholera
- Track 2-16Typhoid fever
- Track 2-17Tetanus
- Track 2-18Zoonotic Bacterial Diseases
- Track 2-19Leprosy
Ebola Virus Disease is caused by virus transmitted through body fluids and through air. It occurs rarely but it is very deadly which results in death and outbreak. Ebola Virus Disease symptoms are very severe which appears in two-three days. Ebola primary symptoms include fever, sore throat, muscular pain and headaches then followed by vomiting, diarrhoea, rash, decreased function of the liver and kidneys then loss of blood internally and externally finally leading to low blood pressure and fluid loss resulting in death.
- Track 3-1Outbreaks
- Track 3-2Epidemiology of Ebola
- Track 3-3Symptoms and pathophysiology
- Track 3-4Diagnosis
- Track 3-5Molecular genetics and current research
- Track 3-6Prevention, control and cure
- Track 3-7Therapeutic measures and vaccination
- Track 3-8Health care
- Track 3-9Public awareness
Fungi are everywhere. There are approximately 1.5 million different species of fungi on Earth, but only about 300 of those are known to make people sick. Fungal diseases are often caused by fungi that are common in the environment. Fungi live outdoors in soil and on plants and trees as well as on many indoor surfaces and on human skin. Most fungi are not dangerous, but some types can be harmful to health. Fungal diseases can affect anyone. Learning about them can help you and your doctor recognize the symptoms of a fungal disease early and may help prevent serious complications. Fungal diseases are often caused by fungi that are common in the environment. Most fungi are not dangerous, but some types can be harmful to health. Mild fungal skin diseases can look like a rash and are very common. Fungal diseases in the lungs are often similar to other illnesses such as the flu or tuberculosis. Some fungal diseases like fungal meningitis and bloodstream infections are less common than skin and lung infections but can be deadly.
- Track 4-1Blastomycosis collapsed
- Track 4-2Susceptibility testing
- Track 4-3Antifungal resistance
- Track 4-4Antifungal drugs & treatment
- Track 4-5Fungal disease epidemiology
- Track 4-6Other pathogenic fungi
- Track 4-7Sporotrichosis collapsed
- Track 4-8Ringworm collapsed
- Track 4-9Pneumocystis pneumonia (PCP) collapsed
- Track 4-10Mucormycosis collapsed
- Track 4-11Histoplasmosis collapsed
- Track 4-12Fungal eye infections collapsed
- Track 4-13C. neoformans infection collapsed
- Track 4-14Coccidioidomycosis (Valley Fever) collapsed
- Track 4-15Candidiasis collapsed
- Track 4-16Ecology and Others
Bacterial resistance is a growing threat and yet few new antibiotics active against multi-resistant bacteria are being explored. A combination of falling profits, regulatory mechanisms and irrational and injudicious use of antibiotics has led to an alarming situation where some infections have no cure. In this article, we summarize the new developments that have been suggested to incentivize the pharmaceutical industries toward the field of infections. We also briefly mention the new compounds on the horizon and some newly approved compounds that might help us tide over this crisis.
- Track 5-1Mechanisms of action, preclinical data & pharmacology
- Track 5-2Pharmacokinetics/pharmacodynamics
- Track 5-3Clinical trials
- Track 5-4Pharmacoepidemiology
- Track 5-5New technologies in the development
- Track 5-6Prescribing Improved agents
- Track 5-7Advancement
Global Market Reports of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
- Track 6-1Disinfection equipments
- Track 6-2Laboratory testing tools
- Track 6-3Chemicals and bulk drugs
- Track 6-4Drug formulation devices
- Track 6-5Municipal water treatment
- Track 6-6Molecular diagnostics
- Track 6-7Testing tools
- Track 6-8Nanomaterials
- Track 6-9Pharmaceuticals
- Track 6-10Environmental products
- Track 6-11Devices and instruments
- Track 6-12Filter media
- Track 6-13Drug device combinations
A parasitic disease is an infectious disease caused or transmitted by a parasite. Many parasites do not cause diseases. Parasitic diseases can affect practically all living organisms, including plants and mammals. The study of parasitic diseases is called parasitology. Some parasites like Toxoplasma gondii and Plasmodium spp. can cause disease directly, but other organisms can cause disease by the toxins that they produce. Although organisms such as bacteria function as parasites, the usage of the term "parasitic disease" is usually more restricted. The three main types of organisms causing these conditions are protozoa (causing protozoan infection), helminths (helminthiasis), and ectoparasites. Protozoa and helminths are usually endoparasites (usually living inside the body of the host), while ectoparasites usually live on the surface of the host. Occasionally the definition of "parasitic disease" is restricted to diseases due to endoparasites.
- Track 7-1Advances in treatment methods
- Track 7-2Diagnosis methods
- Track 7-3Transmission
- Track 7-4New Anti parasitic drugs
- Track 7-5Problems encountered
- Track 7-6Causes and prevention
When a microorganism is isolated from a patient, the microbiology lab will often perform susceptibility testing. There is often confusion about what these results mean and how it can be used by the clinician to guide the treatment of the patient. The goal of antimicrobial susceptibility testing is to predict the in vivo success or failure of antibiotic therapy. Tests are performed in vitro, and measure the growth response of an isolated organism to a particular drug or drugs. The tests are performed under standardized conditions so that the results are reproducible. The test results should be used to guide antibiotic choice. The results of antimicrobial susceptibility testing should be combined with clinical information and experience when selecting the most appropriate antibiotic for your patient.
- Track 8-1MRSA, VRE & other Gram-positives
- Track 8-2Gram-negatives
- Track 8-3Susceptibility testing methods
- Track 8-4Mechanisms of Resistance.
- Track 8-5Bacterial infection in vivo
- Track 8-6Sensitivity Testing Advances
Nosocomial infections are infections are acquired in hospitals and other healthcare facilities. To be classified as a Nosocomial infection, the patient must have been admitted for reasons other than the infection. He or she must also have shown no signs of active or incubating infection. Urinary tract infections are the most common type of nosocomial infection. In the United States, surgical site infections, bloodstream infections, and pneumonia are the other most common types. The location of a nosocomial infection depends on the nature of a patient's hospital procedure.
- Track 9-1Detecting emerging threats in healthcare
- Track 9-2Chances of occurring
- Track 9-3Infection Control
- Track 9-4Intravascular catheter-related infections
- Track 9-5Foreign-body and implant infections
- Track 9-6Surgical site infections
- Track 9-7Surveillance & Epidemiology
- Track 9-8Disinfection
Healthcare-associated infections are a threat to patient safety. Hospitalization for an acute illness, trauma, chronic care, or other health care conditions is a common occurrence. There were 39.2 million hospital discharges in 2005, with an average length of stay of 4.6 days. Hospitalization brings associated risks, including risk of infection. Nosocomial infections, or hospital-associated infections, are estimated to occur in 5 percent of all acute care hospitalizations, or 2 million cases per year. Hospital-associated infections have been identified as one of the most serious patient safety issues in health care. Infections that become clinically evident after 48 hours of hospitalization are considered hospital-associated. Risks factors for hospital-associated infections are generally categorized into three areas: iatrogenic, organizational, or patient-related. Iatrogenic risk factors include invasive procedures (e.g., intubation, indwelling vascular lines, urine catheterization) and antibiotic use and prophylaxis. Organizational risk factors include such things as contaminated air-conditioning systems, contaminated water systems, staffing (e.g., nurse-to-patient ratio), and physical layout of the facility (e.g., open beds close together). Examples of patient-related risk factors include severity of illness, immunosuppression, and length of stay.
- Track 10-1Detecting emerging threats in healthcare
- Track 10-2Tracking and preventing healthcare-associated infections
- Track 10-3Innovative strategies to control and prevent healthcare-associated infections
- Track 10-4Healthcare worker safety/infection control
- Track 10-5Blood, organ, and other tissue safety
The Public Health Practice concentration is geared toward students who are able to enroll in courses that utilize a combination of on-line, video conference, and in person teaching modalities. Students selecting the public health practice program should possess an academic background in a public health related field and/or experience working or volunteering within at least one public health program. Work includes subject matter in the core areas of public health: Epidemiology, Biostatistics, Environmental and occupational health, Public health policy and management, Socio-cultural and behavioral aspects of public health.
- Track 11-1Improvement
- Track 11-2Improving preparedness for infectious disease emergencies
- Track 11-3Role of health communication
- Track 11-4Outbreak investigation: lab and epi response
- Track 11-5Infectious diseases and policy implications
- Track 11-6Strengthening public health systems
The increase in life expectancy during the 20th century is largely due to improvements in child survival; this increase is associated with reductions in infectious disease mortality, due largely to immunization. However, infectious diseases remain a major cause of illness, disability, and death. Immunization recommendations in the United States currently target 17 vaccine-preventable diseases across the lifespan. Healthy People 2020 goals for immunization and infectious diseases are rooted in evidence-based clinical and community activities and services for the prevention and treatment of infectious diseases. Objectives new to Healthy People 2020 focus on technological advancements and ensuring that States, local public health departments, and nongovernmental organizations are strong partners in the Nation’s attempt to control the spread of infectious diseases. Objectives for 2020 reflect a more mobile society and the fact that diseases do not stop at geopolitical borders. Awareness of disease and completing prevention and treatment courses remain essential components for reducing infectious disease transmission.
- Track 12-1Advances and Development
- Track 12-2Vaccine-preventable diseases (VPDs)
- Track 12-3New Approches in Polio Eradication
- Track 12-4Surveillance for VPDs
Respiratory disease is a medical term that encompasses pathological conditions affecting the organs and tissues that make gas exchange possible in higher organisms, and includes conditions of the upper respiratory tract, trachea, bronchi, bronchioles, alveoli, pleura and pleural cavity, and the nerves and muscles of breathing. Respiratory diseases range from mild and self-limiting, such as the common cold, to life-threatening entities like bacterial pneumonia, pulmonary embolism, and lung cancer. The study of respiratory disease is known as pulmonology. A doctor who specializes in respiratory disease is known as a pulmonologist, a chest medicine specialist, a respiratory medicine specialist, a respirologist or a thoracic medicine specialist. UBET Respiratory diseases can be classified in many different ways, including by the organ or tissue involved, by the type and pattern of associated signs and symptoms, or by the cause (aetiology) of the disease.
- Track 13-1H1N1
- Track 13-2Bacterial and Viral Infections
- Track 13-3Prevention challenges for respiratory diseases in community and healthcare settings
- Track 13-4Controlling such diseases
- Track 13-5Others